List of Prevymis drug patents

Prevymis is owned by Merck Sharp Dohme.

Prevymis contains Letermovir.

Prevymis has a total of 3 drug patents out of which 0 drug patents have expired.

Prevymis was authorised for market use on 08 November, 2017.

Prevymis is available in solution;intravenous dosage forms.

The generics of Prevymis are possible to be released after 28 February, 2033.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8513255 MERCK SHARP DOHME Substituted dihydroquinazolines
May, 2024

(11 months from now)

USRE46791 MERCK SHARP DOHME Substituted dihydroquinazolines
May, 2024

(11 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10603384 MERCK SHARP DOHME Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative
Feb, 2033

(9 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Nov 8, 2024

Drugs and Companies using LETERMOVIR ingredient

Market Authorisation Date: 08 November, 2017

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

PREVYMIS family patents

5

European Union

4

United States

3

China

3

Germany

3

Hungary

2

Chile

2

Poland

2

Canada

2

Slovenia

2

Korea, Republic of

2

Ukraine

2

Brazil

2

Hong Kong

2

Morocco

2

Japan

2

Denmark

2

Malaysia

2

Spain

2

Mexico

2

New Zealand

2

Colombia

2

Australia

2

Norway

2

South Africa

2

Portugal

2

Israel

1

ME

1

Philippines

1

Egypt

1

Taiwan

1

Lithuania

1

RS

1

Netherlands

1

Honduras

1

India

1

Croatia

1

Argentina

1

Uruguay

EA

1

EA

1

Ecuador

1

Austria

1

Tunisia

1

Russia

1

Singapore

1

Peru

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in